Skip to content

Growth hormone axis

GHRP-6

Also called SKF-110679

InjectableEvidence BTwice a day
Half-life
0.3hours
Typical vial
5 / 10mg
Research amounts
100–200mcg

per administration

Common schedule
Twice a day
Some human use

It has been used in people, but no trial has settled how much or how often.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded6units dialled
Concentration
1.67mg/mL
Volume per draw
0.06mL
Units to dial
6
Doses per cartridge
50

Vial label

Copy this into your label printer.

Published research contexts for GHRP-6 describe 100200 mcg per administration. Descriptive only, not a recommendation.

Roughly 15–20 minutes in plasma.

An early growth-hormone-releasing hexapeptide given to human volunteers, but no trial fixes a subcutaneous amount or schedule; the circulating figures are community-derived, so no schedule table is shown.

Modelled level — twice a day

1× is the peak after a single dose.

Steady-state peak
1.00× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
2hours

About five half-lives

Administrations
14/ week

Where these numbers come from

  • GHRP-6 (SKF-110679) secretagogue literatureOne of the first growth-hormone-releasing peptides taken into human study; injected amounts in circulation are community-derived, not trial-established.

Next steps